NCT07278921
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- IRCCS Ospedale San Raffaele Milan, Italy
Clinical trial condition
Lymphoma, Follicular
Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.
1,362 public trials
202 recruiting studies
Lymphoma, Follicular trial results
NCT07114939
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +16 more
- Locations
-
- University of Pennsylvania, Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
NCT04390737
- Conditions
- Advanced Solid Tumor, Epithelioid Sarcoma, FL Lymphoma, +15 more
- Locations
-
- Mayo Clinic Phoenix, Arizona, United States
- Mayo Clinic Jacksonville, Florida, United States
- Mayo Clinic Rochester, Minnesota, United States
- NEXT Oncology San Antonio, Texas, United States
NCT04669171
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
- Locations
-
- Dana Farber Cancer Institute Boston, Massachusetts, United States
- Mayo Clinic Rochester, Minnesota, United States
- University of Rochester Medical Center (URMC) - Wilmot Cancer Institute (WCI) (James P. Wilmot Cancer Center) Rochester, New York, United States
- University of Washington-Seattle Cancer Care Alliance Seattle, Washington, United States
NCT06492837
- Conditions
- Follicular Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
- Locations
-
- Royal Adelaide Hospital Adelaide, Australia
- Liverpool Hospital Liverpool, Australia
- St. Vincent Hospital Melbourne Melbourne, Australia
- Princess Alexandra Hospital Woolloongabba, Australia
NCT06667687
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +12 more
- Locations
-
- Carolina BioOncology Institute /ID# 265259 Huntersville, North Carolina, United States
- Willamette Valley Cancer Institute and Research Center /ID# 270945 Eugene, Oregon, United States
- Texas Oncology - Central/South Texas /ID# 270946 Austin, Texas, United States
- START Mountain Region /ID# 267592 West Valley City, Utah, United States
Recruiting
Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma
NCT07077512
- Conditions
- Follicular Lymphoma ( FL), Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Sun Yat-sen Universitiy Cancer Center Guangzhou, China
- Fifth Affiliated Hospital of Guangzhou Medical University Guangzhou, China
- Guangzhou overseas Chinese hospital Guangzhou, China
- Conditions
- Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue, Follicular Lymphoma, Hemic and Lymphatic Diseases, +16 more
- Locations
-
- Lineberger Comprehensive Cancer Center at University of North Carolina Chapel Hill, North Carolina, United States
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Diffuse Large B-cell Lymphoma, +21 more
- Locations
-
- University of Arizona Cancer Center - Tucson /ID# 247752 Tucson, Arizona, United States
- Sylvester Comprehensive Cancer Center - University of Miami /ID# 247232 Miami, Florida, United States
- Allina Health System /ID# 251782 Minneapolis, Minnesota, United States
- University of Nebraska Medical Center /ID# 246715 Omaha, Nebraska, United States
NCT04792502
- Conditions
- B-cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +12 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- Lifespan Cancer Insitute Providence, Rhode Island, United States